Dr. Kwong Yok Lam - Haematology & Haematological Oncology
Highlights
- MCHK RegisteredVerified
- TrilingualCantonese · English · Putonghua
- Specialist in Haematology & Haematological OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Member of the Royal Colleges of Physicians of the United Kingdom · Member of the Royal College of Pathologists · Medical degree 1983
- InsuranceBeing compiled|See details
About
Dr. Kwong Yok Lam is a registered Haematology & Haematological Oncology specialist in Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1983
- Member of the Royal Colleges of Physicians of the United KingdomMember of the Royal Colleges of Physicians of the United Kingdom1986
- Member of the Royal College of PathologistsMember of the Royal College of Pathologists1991
- Fellow of the Hong Kong Academy of Medicine (Medicine)Fellow of the Hong Kong Academy of Medicine (Medicine)1993
- FHKCPathFellow, The Hong Kong College of Pathologists1993
- FHKCPFellow, Hong Kong College of Physicians1993
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
Department of Medicine Queen Mary Hospital 102 Pokfulam Road Hong Kong
Fax: +852 2974 1165
Insurance
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Kwong Yok Lam? Claim page and update insurance →
FAQ
Research and publications
144 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Immune Checkpoint Blockade in Hematological Malignancies: Current Status and Future Directions.Cancers · 2026
- Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction.Blood advances · 2026
- Extranodal natural killer/T-cell lymphoma: From fatal to curable.CA: a cancer journal for clinicians · 2026
- Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice.Annals of hematology · 2026
- Fibrin-associated large B-cell lymphoma occurring in an ancient retroperitoneal schwannoma.British journal of haematology · 2026
- Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome.Blood advances · 2025
- Epidemiology of mature T-cell and NK-cell neoplasms: east and west.The Lancet regional health. Western Pacific · 2025
- Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia.British journal of haematology · 2025
- Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation.Annals of hematology · 2025
- A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.International journal of cancer · 2024
- Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.Annals of hematology · 2024
- Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM.Bone marrow transplantation · 2024
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer